{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:22:35Z","timestamp":1776871355030,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Key Project of Chinese Ministry of Science and Technology","award":["2013ZX10002001"],"award-info":[{"award-number":["2013ZX10002001"]}]},{"name":"Science Foundation of Qilu Hospital of Shandong University","award":["2016QLQN05"],"award-info":[{"award-number":["2016QLQN05"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171579"],"award-info":[{"award-number":["81171579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201287"],"award-info":[{"award-number":["81201287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10238-017-0480-3","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T10:33:02Z","timestamp":1511260382000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Increased BATF expression is associated with the severity of liver damage in patients with chronic hepatitis B"],"prefix":"10.1007","volume":"18","author":[{"given":"Li-Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Fen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-0147","authenticated-orcid":false,"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"480_CR1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u20132.","journal-title":"Hepatology"},{"key":"480_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/hep.23273","volume":"51","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51:81\u201391.","journal-title":"Hepatology"},{"issue":"8","key":"480_CR3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/vim.2015.0024","volume":"28","author":"H Feng","year":"2015","unstructured":"Feng H, Yin J, Han YP, et al. Sustained changes of Treg and Th17 cells during interferon-\u03b1 therapy in patients with chronic hepatitis B. Viral Immunol. 2015;28(8):412\u20137.","journal-title":"Viral Immunol"},{"key":"480_CR4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10875-009-9328-2","volume":"30","author":"J Ge","year":"2010","unstructured":"Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010;30:60\u20137.","journal-title":"J Clin Immunol"},{"issue":"765\u201376","key":"480_CR5","first-page":"e1","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng F, Wang K, Aoyama T, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology. 2012;143(765\u201376):e1\u20133.","journal-title":"Gastroenterology"},{"key":"480_CR6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.antiviral.2012.12.018","volume":"97","author":"B Wang","year":"2013","unstructured":"Wang B, Zhao XP, Fan YC, Zhang JJ, Zhao J, Wang K. IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line. Antiviral Res. 2013;97:285\u201392.","journal-title":"Antiviral Res"},{"key":"480_CR7","first-page":"2255","volume":"11","author":"MJ Dorsey","year":"1995","unstructured":"Dorsey MJ, Tae HJ, Sollenberger KG, Mascarenhas NT, Johansen LM, Taparowsky EJ. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene. 1995;11:2255\u201365.","journal-title":"Oncogene"},{"key":"480_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/bbrc.1996.0700","volume":"222","author":"H Hasegawa","year":"1996","unstructured":"Hasegawa H, Utsunomiya Y, Kishimoto K, Tange Y, Yasukawa M, Fujita S. SFA-2, a novel bZIP transcription factor induced by human T-cell leukemia virus type I, is highly expressed in mature lymphocytes. Biochem Biophys Res Commun. 1996;222:164\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"480_CR9","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/sj.onc.1203491","volume":"19","author":"DR Echlin","year":"2000","unstructured":"Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene. 2000;19:1752\u201363.","journal-title":"Oncogene"},{"key":"480_CR10","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3","volume":"31","author":"KL Williams","year":"2001","unstructured":"Williams KL, Nanda I, Lyons GE, et al. Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur J Immunol. 2001;31:1620\u20137.","journal-title":"Eur J Immunol"},{"key":"480_CR11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s003359900881","volume":"9","author":"NP Meyer","year":"1998","unstructured":"Meyer NP, Johansen LM, Tae HJ, Budde PP, Williams KL, Taparowsky EJ. Genomic organization of human B-ATF, a target for regulation by EBV and HTLV-1. Mamm Genome. 1998;9:849\u201352.","journal-title":"Mamm Genome"},{"key":"480_CR12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20091548","volume":"207","author":"BC Betz","year":"2010","unstructured":"Betz BC, Jordan-Williams KL, Wang C, et al. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J Exp Med. 2010;207:933\u201342.","journal-title":"J Exp Med"},{"key":"480_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.03.004","author":"N Sopel","year":"2016","unstructured":"Sopel N, Graser A, Mousset S, Finotto S. The transcription factor BATF modulates cytokine-mediated responses in T cells. Cytokine Growth Factor Rev. 2016;. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.03.004 .","journal-title":"Cytokine Growth Factor Rev"},{"key":"480_CR14","doi-asserted-by":"crossref","first-page":"14885","DOI":"10.1073\/pnas.1105133108","volume":"108","author":"S Kuroda","year":"2011","unstructured":"Kuroda S, Yamazaki M, Abe M, Sakimura K, Takayanagi H, Iwai Y. Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression. Proc Natl Acad Sci USA. 2011;108:14885\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"480_CR15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.celrep.2015.09.069","volume":"13","author":"G Xin","year":"2015","unstructured":"Xin G, Schauder DM, Lainez B, et al. A critical role of IL-21-induced BATF in sustaining CD8-T-cell-mediated chronic viral control. Cell Rep. 2015;13(6):1118\u201324.","journal-title":"Cell Rep"},{"key":"480_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08114","volume":"460","author":"BU Schraml","year":"2009","unstructured":"Schraml BU, Hildner K, Ise W, et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature. 2009;460:405\u20139.","journal-title":"Nature"},{"key":"480_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1126\/science.1228309","volume":"338","author":"E Glasmacher","year":"2012","unstructured":"Glasmacher E, Agrawal S, Chang AB, et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science. 2012;338:975\u201380.","journal-title":"Science"},{"issue":"8","key":"480_CR18","first-page":"3603","volume":"8","author":"B Yang","year":"2016","unstructured":"Yang B, He F, Dai C, et al. BATF inhibition prevent acute allograft rejection after cardiac transplantation. Am J Transl Res. 2016;8(8):3603\u201313.","journal-title":"Am J Transl Res"},{"issue":"7","key":"480_CR19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/gutjnl-2014-308227","volume":"65","author":"E Punkenburg","year":"2016","unstructured":"Punkenburg E, Vogler T, B\u00fcttner M, et al. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer. Gut. 2016;65(7):1139\u201350.","journal-title":"Gut"},{"key":"480_CR20","doi-asserted-by":"publisher","first-page":"e1002272","DOI":"10.1371\/journal.ppat.1002272","volume":"7","author":"PM Smith","year":"2011","unstructured":"Smith PM, Jacque B, Conner JR, Poltorak A, Stadecker MJ. IRAK-2 regulates IL-1-mediated pathogenic Th17 cell development in helminthic infection. PLoS Pathog. 2011;7:e1002272. https:\/\/doi.org\/10.1371\/journal.ppat.1002272 .","journal-title":"PLoS Pathog"},{"key":"480_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"EASL Clinical Practice Guidelines","year":"2012","unstructured":"EASL Clinical Practice Guidelines. Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167\u201385.","journal-title":"J Hepatol"},{"key":"480_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","volume":"2","author":"YF Liaw","year":"2008","unstructured":"Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008;2:263\u201383.","journal-title":"Hepatol Int"},{"key":"480_CR23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida JA, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009;3:269\u201382.","journal-title":"Hepatol Int"},{"key":"480_CR24","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13:372\u20134.","journal-title":"J Hepatol"},{"key":"480_CR25","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1158\/1078-0432.CCR-08-3224","volume":"15","author":"Y Lorenzo","year":"2009","unstructured":"Lorenzo Y, Provencio M, Lombardia L, et al. Differential genetic and functional markers of second neoplasias in Hodgkin\u2019s disease patients. Clin Cancer Res. 2009;15:4823\u20138.","journal-title":"Clin Cancer Res"},{"key":"480_CR26","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1002\/cncr.25224","volume":"116","author":"YH Chang","year":"2010","unstructured":"Chang YH, Yu CW, Lai LC, et al. Up-regulation of interleukin-17 expression by human papillomavirus type 16 E6 in nonsmall cell lung cancer. Cancer. 2010;116:4800\u20139.","journal-title":"Cancer"},{"key":"480_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/jhep.2000.16470","volume":"32","author":"M Nagao","year":"2000","unstructured":"Nagao M, Nakajima Y, Kanehiro H, et al. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma. Hepatology. 2000;32:491\u2013500.","journal-title":"Hepatology"},{"key":"480_CR28","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2893.2012.01603.x","volume":"19","author":"ZX Qi","year":"2012","unstructured":"Qi ZX, Wang LY, Fan YC, Zhang JJ, Li T, Wang K. Increased peripheral RORalpha and RORgammat mRNA expression is associated with acute-on-chronic hepatitis B liver failure. J Viral Hepat. 2012;19:811\u201322.","journal-title":"J Viral Hepat"},{"key":"480_CR29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1743-422X-8-113","volume":"8","author":"W Wu","year":"2011","unstructured":"Wu W, Shi Y, Li J, Chen F, Chen Z, Zheng M. Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection. Virol J. 2011;8:113.","journal-title":"Virol J"},{"key":"480_CR30","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.4049\/jimmunol.151.10.5123","volume":"151","author":"SJ Anderson","year":"1993","unstructured":"Anderson SJ, Coleclough C. Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms. J Immunol. 1993;151:5123\u201334.","journal-title":"J Immunol"},{"key":"480_CR31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.V86.4.1408.bloodjournal8641408","volume":"86","author":"LJ Picker","year":"1995","unstructured":"Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory\/effector T cells by flow cytometry. Blood. 1995;86:1408\u201319.","journal-title":"Blood"},{"key":"480_CR32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","volume":"95","author":"N Figueroa-Vega","year":"2010","unstructured":"Figueroa-Vega N, Alfonso-Perez M, Benedicto I, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab. 2010;95:953\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"480_CR33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.2232","volume":"16","author":"M Quigley","year":"2010","unstructured":"Quigley M, Pereyra F, Nilsson B, et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med. 2010;16:1147\u201351.","journal-title":"Nat Med"},{"key":"480_CR34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4049\/jimmunol.1200868","volume":"190","author":"T Miao","year":"2013","unstructured":"Miao T, Raymond M, Bhullar P, et al. Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf. J Immunol. 2013;190:58\u201365.","journal-title":"J Immunol"},{"key":"480_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.virol.2005.04.027","volume":"337","author":"MH Rasmussen","year":"2005","unstructured":"Rasmussen MH, Sorensen AB, Morris DW, et al. Tumor model-specific proviral insertional mutagenesis of the Fos\/Jdp2\/Batf locus. Virology. 2005;337:353\u201364.","journal-title":"Virology"},{"key":"480_CR36","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1128\/JVI.77.10.6029-6040.2003","volume":"77","author":"LM Johansen","year":"2003","unstructured":"Johansen LM, Deppmann CD, Erickson KD, et al. EBNA2 and activated Notch induce expression of BATF. J Virol. 2003;77:6029\u201340.","journal-title":"J Virol"},{"key":"480_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.lab.2005.10.003","volume":"147","author":"X Zhang","year":"2006","unstructured":"Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med. 2006;147:58\u201366.","journal-title":"J Lab Clin Med"},{"key":"480_CR38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/JVI.66.2.983-991.1992","volume":"66","author":"R Lucito","year":"1992","unstructured":"Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol. 1992;66:983\u201391.","journal-title":"J Virol"},{"key":"480_CR39","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.1074\/jbc.M100846200","volume":"276","author":"J Li","year":"2001","unstructured":"Li J, Peet GW, Balzarano D, et al. Novel NEMO\/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J Biol Chem. 2001;276:18579\u201390.","journal-title":"J Biol Chem"},{"key":"480_CR40","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1038\/sj.onc.1205918","volume":"21","author":"T Senga","year":"2002","unstructured":"Senga T, Iwamoto T, Humphrey SE, Yokota T, Taparowsky EJ, Hamaguchi M. Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells. Oncogene. 2002;21:8186\u201391.","journal-title":"Oncogene"},{"key":"480_CR41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/1541-7786.MCR-10-0375","volume":"9","author":"J Liao","year":"2011","unstructured":"Liao J, Humphrey SE, Poston S, Taparowsky EJ. Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells. Mol Cancer Res. 2011;9:350\u201363.","journal-title":"Mol Cancer Res"},{"key":"480_CR42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","volume":"156","author":"G Rong","year":"2009","unstructured":"Rong G, Zhou Y, Xiong Y, et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. Clin Exp Immunol. 2009;156:217\u201325.","journal-title":"Clin Exp Immunol"},{"key":"480_CR43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10875-011-9518-6","volume":"31","author":"F Meng","year":"2011","unstructured":"Meng F, Wang J, Ge J, et al. Alteration of interferon-alpha\/beta receptors in chronic hepatitis B patients. J Clin Immunol. 2011;31:521\u201332.","journal-title":"J Clin Immunol"},{"key":"480_CR44","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/srep01754","volume":"3","author":"S Koch","year":"2013","unstructured":"Koch S, Mousset S, Graser A, et al. IL-6 activated integrated BATF\/IRF4 functions in lymphocytes are T-bet-independent and reversed by subcutaneous immunotherapy. Sci Rep. 2013;3:1754.","journal-title":"Sci Rep"},{"key":"480_CR45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature11530","volume":"490","author":"P Li","year":"2012","unstructured":"Li P, Spolski R, Liao W, et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature. 2012;490:543\u20136.","journal-title":"Nature"},{"key":"480_CR46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri3470","volume":"13","author":"TL Murphy","year":"2013","unstructured":"Murphy TL, Tussiwand R, Murphy KM. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat Rev Immunol. 2013;13:499\u2013509.","journal-title":"Nat Rev Immunol"},{"key":"480_CR47","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","volume":"58","author":"FV Chisari","year":"2010","unstructured":"Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 2010;58:258\u201366.","journal-title":"Pathol Biol (Paris)"},{"key":"480_CR48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R, Wieland S, Steiger C, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77:68\u201376.","journal-title":"J Virol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-017-0480-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-017-0480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-017-0480-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T20:05:24Z","timestamp":1693253124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-017-0480-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["480"],"URL":"https:\/\/doi.org\/10.1007\/s10238-017-0480-3","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}